Loading...
MicroTech Medical (Hangzhou) Co., Ltd.
2235.HK•HKSE
Healthcare
Medical - Devices
HK$6.95
HK$0.05(0.72%)

The company's financials show resilient growth, with revenue advancing from $55.41M in Q2 2023 to $150.82M in Q2 2024. Gross profit remained healthy with margins at 56% in Q2 2024 compared to 52% in Q2 2023. Operating income hit -$37.71M last quarter, sustaining a consistent -25% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$65.97M. Net income rose to -$37.74M, while earnings per share reached -$0.09. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan